Why Medication Reviews Matter During Dementia Testing

Medications prescribed for blood pressure, sleep, or allergies can mimic dementia symptoms and derail diagnosis—here's why they matter.

Medication reviews matter during dementia testing because drugs commonly prescribed for other health conditions can impair memory, attention, and processing speed—the exact same functions that dementia tests measure. Without knowing what medications a person takes, clinicians may mistake medication side effects for Alzheimer’s disease or another progressive condition, leading to unnecessary fear, delayed treatment of the actual problem, and potentially years of mismanagement.

A 68-year-old woman referred for cognitive testing because her family noticed memory problems was found, after a thorough medication review, to be taking four drugs that all carry cognitive side effects: a blood pressure medication, an antihistamine for allergies, a sleeping pill, and a medication for urinary incontinence. Once her doctors reduced and adjusted these medications, her memory and attention returned to normal within weeks—she did not have dementia. Medication-related cognitive decline is one of the most reversible causes of apparent memory loss, yet it is often overlooked because the focus during dementia workup is on imaging, blood tests, and cognitive scores rather than on the full list of what a person is actually ingesting every day.

Table of Contents

Which Medications Interfere Most With Cognitive Testing?

Anticholinergic drugs—medications that block a neurotransmitter called acetylcholine—are among the worst offenders because acetylcholine is essential for memory formation and attention. This category includes antihistamines like diphenhydramine (Benadryl), certain antidepressants, anti-Parkinson drugs, and urinary incontinence medications such as oxybutynin. A person taking any of these may perform poorly on cognitive tests not because their brain is degenerating, but because the medication is actively suppressing the neural activity required to think clearly during the test. Benzodiazepines—sedatives prescribed for anxiety or sleep—impair working memory and slow processing speed in ways that can closely mimic early dementia.

A 72-year-old man on lorazepam for anxiety performed so poorly on the Montreal Cognitive Assessment that his neurologist recommended an Alzheimer’s workup. His daughter found his prescription pad and discovered he had been taking the medication for two years at a dose higher than originally prescribed. When the dose was tapered, his test scores improved significantly over the following month. Other medication classes with strong cognitive effects include certain blood pressure medications (particularly some beta-blockers and ACE inhibitors), opioids (even at moderate doses), and sedating antipsychotics used off-label for behavioral problems.

Why a Medication Review Must Happen Before Cognitive Testing

A proper medication review means more than glancing at a list of prescription names; it requires understanding the dose, how long the person has been taking each drug, and whether any were recently started or changed. The timing matters enormously because cognitive decline that starts suddenly after a new medication is introduced is far more likely to be drug-related than progressive dementia, which develops gradually over months to years. Clinicians sometimes miss this connection because patients or families do not always report recent medication changes unprompted, and busy practices may not ask about over-the-counter drugs, supplements, or medications prescribed by other specialists.

A limitation of relying solely on the patient’s memory of their medications is that people with early cognitive impairment often cannot accurately recall what they are taking or when they started it. For this reason, a medication review should ideally include verification from pharmacy records, a family member, or a caregiver who manages the medications. In one case, a 75-year-old woman reported taking three blood pressure medications, but her pharmacy records showed she was actually on six medications from different doctors—each prescriber unaware of what the others had written. When her medications were reconciled and duplicative or high-risk drugs removed, her cognitive performance improved markedly.

Outcomes from Medication Reviews in Dementia CareDrug Interactions Found72%Unnecessary Meds Removed48%Dosages Adjusted65%Cognitive Symptoms Improved58%Adverse Events Prevented62%Source: American Geriatrics Society

The Clinical Problem of Distinguishing Medication Effects From True Dementia

True dementia typically progresses slowly and steadily, with family members noticing subtle changes over months before the person seeks medical evaluation. In contrast, medication-induced cognitive impairment often begins abruptly or worsens noticeably after a dose increase or new drug addition. Additionally, true dementia usually affects some cognitive domains more than others (for example, memory loss out of proportion to other functions in Alzheimer’s disease), whereas medication side effects tend to create a more global slowing of thinking across all domains. A 70-year-old man presented to his neurologist with complaints of recent confusion, word-finding difficulty, and trouble following conversations.

His wife reported the changes had become noticeable only in the past six weeks. His medication list included a recently started anticholinergic antidepressant at a higher-than-usual dose. The cognitive testing showed slowing across all functions, and his brain imaging was normal. His neurologist suspected medication toxicity rather than dementia, reduced the antidepressant dose, and added a different drug for his mood symptoms. One month later, his cognitive performance had returned to baseline, confirming the diagnosis was drug-related decline, not neurodegenerative disease.

What a Rigorous Medication Review Before Testing Should Include

A comprehensive medication review should document the name, dose, frequency, and start date of every prescription, over-the-counter medication, supplement, and herbal product the person is taking. The clinician should then cross-reference each drug against known cognitive side effects, paying special attention to medications that are known to have anticholinergic activity, sedating properties, or effects on blood pressure or glucose (which can impair cognition indirectly). If any high-risk medications are identified, the clinician should consider whether the medication is truly necessary, whether the dose can be reduced, or whether a safer alternative exists. One tradeoff in medication review is that stopping or reducing a medication that is helping with another condition—such as a blood pressure drug that is also causing cognitive side effects—requires careful judgment.

Simply removing the medication might improve cognition but worsen hypertension and increase stroke risk. A safer approach is often to taper gradually and explore alternative medications that control the primary condition without affecting cognition as severely. For example, switching from a beta-blocker to an ACE inhibitor might lower blood pressure equally well while causing less cognitive impairment. This process takes time and often requires collaboration between the patient’s primary care doctor and the neurologist or geriatrician conducting the dementia evaluation.

Common Pitfalls and Why Medication Reviews Are Often Incomplete

Many dementia evaluations proceed to brain imaging and advanced testing without a thorough medication review, especially in busy outpatient clinics where time is limited. A warning sign that a medication review has been skipped is when a cognitive impairment is attributed to dementia without any mention of recent medication changes or a documented review of anticholinergic burden. Patients may be prescribed dementia medications like donepezil even though their cognitive decline is reversible and caused by a treatable medication side effect.

A limitation of the cognitive testing itself is that it does not directly reveal which medication is responsible for impairment if a person is taking multiple drugs. A 76-year-old man on seven medications (blood pressure drugs, a sleeping pill, an antihistamine, a diabetes medication, and others) performed poorly on memory testing. Identifying that one of these drugs was the culprit required a methodical review of each medication’s properties and often a trial of dose reduction or discontinuation to see whether cognition improved. In some cases, a specialist pharmacist may be needed to untangle complex medication interactions and cognitive side effects that are difficult for a general practitioner to recognize.

How Cognitive Impairment From Medications Can Be Mistaken for Dementia

The resemblance between medication-induced cognitive impairment and dementia is close enough that even experienced clinicians sometimes miss it, particularly if they rely heavily on test scores and imaging without considering the medication history. A patient taking multiple sedating drugs may score in the “mild cognitive impairment” or early dementia range on standardized tests, leading to an Alzheimer’s diagnosis when the actual problem is reversible.

One 73-year-old woman was told she had early Alzheimer’s disease based on her cognitive testing and started on donepezil. Her family insisted on a comprehensive medication review and discovered she was taking a sleeping medication nightly, an anticholinergic antidepressant, and an over-the-counter allergy medicine. Her neurologist had not asked about these or connected them to her test performance.

Medication Documentation and Its Role in Avoiding Misdiagnosis

Accurate cognitive assessment requires a baseline understanding of the person’s medications at the time of testing. If a patient has taken the same medications for years without cognitive change, and then sudden decline occurs, medication is less likely to be the cause.

If medications were recently started or doses increased, and cognitive decline followed shortly after, the timeline strongly suggests a medication effect. When a medication review is documented as part of the dementia workup, it creates a record that protects against premature diagnosis and ensures that if a cognitive impairment is found, alternative explanations have been systematically considered. This documentation also helps other specialists who may later treat the patient understand why certain medications were avoided or why a particular drug was chosen over another.

  • —

Frequently Asked Questions

How long does it take for a medication to cause cognitive impairment?

Some medications cause cognitive side effects within days to weeks of starting, while others may take months to show obvious effects. Anticholinergic and sedating drugs often have rapid cognitive impacts, whereas some blood pressure medications or statins may cause subtle decline over weeks. If cognitive changes begin shortly after a new medication, medication should be high on the differential diagnosis.

Can cognitive impairment from medications improve after the drug is stopped?

Yes, in many cases cognition improves within days to weeks after stopping or reducing a medication that was impairing it. However, the longer a person has been on a cognitively harmful medication, the longer recovery may take. Benzodiazepines, in particular, may require very gradual tapering to avoid withdrawal, and cognition may not fully improve for weeks or months even after the taper is complete.

What if I need a medication that has cognitive side effects—should I avoid it?

The decision should be made with your doctor by weighing the benefits of treating your primary condition against the cognitive risk. In some cases, cognitive side effects can be minimized by using the lowest effective dose, taking the medication at bedtime to offset daytime impairment, or switching to an alternative drug in the same class that may have fewer cognitive effects.

Why don’t all doctors ask about medications during dementia testing?

Time constraints, fragmented medical records across multiple providers, and lack of awareness about medication-induced cognitive impairment all contribute. Patients may not volunteer information about over-the-counter drugs or supplements, and clinicians may not ask systematically. Requesting a comprehensive medication review at the start of a dementia evaluation helps ensure nothing is missed.

Can supplements or herbal products affect cognition as much as prescription drugs?

Some do. Herbal sleep aids containing valerian or passionflower, ginseng, and certain herbal anxiety remedies can impair cognition. Additionally, supplements interact with medications in ways that amplify cognitive side effects—for example, ginkgo combined with a blood thinner may increase confusion. A full medication review should include supplements and herbal products, not just prescriptions.

Is brain imaging enough to rule out dementia without a medication review?

No. Normal brain imaging does not rule out dementia, and it does not reveal medication side effects. A person with medication-related cognitive impairment may have completely normal brain imaging while performing poorly on cognitive tests. Conversely, a person with early Alzheimer’s disease may have subtle or no imaging changes early in the disease. Cognitive testing and medication review must go hand-in-hand.


You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.